| Structure |
Chemical Name |
CAS |
MF |
 |
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
 |
2-bromo-N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)benzenesulfonamide |
415697-57-3 |
C13H15BrN2O4S |
![(1S,3R,5S)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid](/CAS/20180601/GIF/1417743-41-9.gif) |
(1S,3R,5S)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid |
1417743-41-9 |
C11H17NO4 |
![2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/CAS/20180531/GIF/1187594-13-3.gif) |
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
 |
Eribulin intermediate |
253128-15-3 |
C40H58O12 |
 |
tert-butyl 2-(azetidin-3-yl)acetate hydrochloride |
2173991-98-3 |
C9H18ClNO2 |
 |
Δ3-Flomoxef sodium |
|
|
 |
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
 |
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
 |
5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide |
31127-80-7 |
C16H20I3N3O7 |
 |
(+)-beta-Pinene oxide |
6931-54-0 |
C10H16O |
 |
Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate |
64485-82-1 |
C7H9N3O3S |
 |
1H-Tetrazole-1-acetic acid |
21732-17-2 |
C3H4N4O2 |
 |
3-Bromo-5-fluoroanisole |
29578-39-0 |
C7H6BrFO |
 |
Allopregnanolone |
516-54-1 |
C21H34O2 |
 |
4-Methylimidazole |
822-36-6 |
C4H6N2 |
 |
(R)-ethyl thiazolidine-4-carboxylate |
|
C6H11NO2S |
 |
Ranolazine-d3 |
1054624-77-9 |
C24H33N3O4 |
![N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride](/CAS/20150408/GIF/1260590-51-9.gif) |
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
1260590-51-9 |
C13H19N5.ClH |
![tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate](/CAS/20150408/GIF/1172623-99-2.gif) |
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
 |
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
 |
Coumarin |
10172-76-6 |
C27H21NO6 |
 |
Pemetrexed intermediate |
|
|
 |
R-Avanafil |
1638497-26-3 |
C23H26ClN7O3 |
 |
(2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2-
trifluoro acetate salt |
676560-85-3 |
C10H16F3NO4 |
 |
,100kg |
180048-73-1 |
C11H14O4S |
 |
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
 |
tert-butyl 4-(4-bromothiazol-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate |
1332301-87-7 |
C13H17BrN2O2S |
 |
PPAP |
784118-64-5 |
C14H23N |
 |
Acalabrutinib Intermediate |
1420478-90-5 |
C22H21N7O |
 |
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
 |
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
![(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone](/CAS/20180703/GIF/1027552-46-0.gif) |
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
 |
4F-MPH |
1354631-33-6 |
C14H18FNO2 |
 |
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
 |
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
 |
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
![tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate](/CAS/20180529/GIF/1403901-49-4.gif) |
tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate |
1403901-49-4 |
C14H19BrN2O2 |
 |
2H-1-Benzopyran-2-one, 6-chloro-4-methyl- |
24145-78-6 |
C10H7ClO2 |
![4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid](/CAS/20180529/GIF/864725-62-2.gif) |
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid |
864725-62-2 |
C18H12Cl2F3NO3 |
 |
Cefixime Impurity B(7E) |
|
|
 |
-- |
93360-08-8 |
C30H27N2O6P |
 |
5-Benzylidenehydantoin |
3775-01-7 |
C10H8N2O2 |
![5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester](/CAS/GIF/147125-14-2.gif) |
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
 |
Clopidogrel camphorsulfonate |
120202-68-8 |
C26H32ClNO6S2 |
![(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)](/CAS/GIF/130793-28-1.gif) |
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |
130793-28-1 |
C29H55NO6 |
 |
1-Phenyl-3-(2-hydroxyethyl)thiourea |
102-12-5 |
C9H12N2OS |
 |
NA |
58500-79-1 |
C6Fe2O6S2 |
 |
N4-Acetyl-2'-O-Methyl-cytidine |
113886-71-8 |
C12H17N3O6 |
![5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine](/CAS2/GIF/1010120-55-4.gif) |
5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine |
1010120-55-4 |
C6H5BrN4 |
 |
Cis-(1s,3s)-3-(2-methoxyphenyl)cyclobutan-1-amine hydrochloride |
|
|
 |
4,4'-Dibromo-2,2'-diiodobiphenyl |
852138-89-7 |
C12H6Br2I2 |
 |
Sterolazole intermediate |
|
|
 |
2',3'-Anhydroinosine |
31766-13-9 |
C10H10N4O4 |
 |
Tadanafil intermediate (chloroacetyl porphyrin) |
171596-59-1 |
C31H57BN4O6Si |
 |
6-BROMO-4-HYDROXYCOUMARIN |
4139-61-1 |
C9H5BrO3 |
 |
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
357326-79-5 |
C10H15NO3 |
 |
Ethyl 4,4-difluoro-3-oxobutanoate |
352-24-9 |
C6H8F2O3 |
 |
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
 |
RET-IN-1 |
2222755-14-6 |
C29H31N9O3 |
![1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)-](/CAS/20200331/GIF/1403902-78-2.gif) |
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
 |
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
 |
Dimethyl 4-aminothiophene-2,3-dicarboxylate hydrochloride |
121071-71-4 |
C8H10ClNO4S |
 |
Berberine Impurity 13 |
55971-02-3 |
C20H16NO4.Cl |
 |
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
 |
Thionicotinamide |
4621-66-3 |
C6H6N2S |
 |
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
![1-([(9H-Fluoren-9-ylmethoxy)carbonyl]amino)-3,3-difluorocyclobutane-1-carboxylic acid](/CAS/20200331/GIF/1936532-04-5.gif) |
1-([(9H-Fluoren-9-ylmethoxy)carbonyl]amino)-3,3-difluorocyclobutane-1-carboxylic acid |
1936532-04-5 |
C20H17F2NO4 |
 |
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
 |
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
![(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate](/CAS/20211123/GIF/1428484-17-6.gif) |
(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate |
1428484-17-6 |
C36H51F5O4S |
 |
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
 |
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
 |
2’-deoxyinosine |
|
|
 |
((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol hydrochloride |
2416218-32-9 |
C8H14FNO.ClH |
![(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol](/CAS/GIF/150-05-0.gif) |
(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol |
150-05-0 |
C9H13NO3 |
 |
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
![5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester](/CAS/20211123/GIF/1847464-89-4.gif) |
5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847464-89-4 |
C29H35N7O5 |
![Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)-](/CAS/20210305/GIF/2145122-45-6.gif) |
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
 |
4-MAR |
|
|
 |
27-Demethyl Rifampicin |
|
|
 |
Sunitinib Malate E-Isomer |
|
|
 |
Δ3-Ceftiofur |
|
|
![2-Propenamide, N-[2-(phosphonooxy)ethyl]-](/CAS/20210305/GIF/146222-14-2.gif) |
2-Propenamide, N-[2-(phosphonooxy)ethyl]- |
146222-14-2 |
C5H10NO5P |
 |
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
 |
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
![(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide](/CAS/20210305/GIF/2209874-02-0.gif) |
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
 |
20-hydroxy Prostaglandin F2a |
|
|
![1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)-](/CAS/20210305/GIF/2209874-17-7.gif) |
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
 |
Methyl 5-amino-2,4-difluorobenzoate |
125568-73-2 |
C8H7F2NO2 |
 |
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
 |
CALCIUM PIDOLATE |
31377-05-6 |
C10H12CaN2O6 |
 |
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
 |
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
 |
Chloropretadalafil |
171489-59-1 |
C22H19ClN2O5 |
 |
Minepentate |
13877-99-1 |
C18H27NO3 |
![5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide](/CAS/GIF/89729-09-9.gif) |
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
 |
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
 |
3-FLUOROINDOLE |
66946-81-4 |
C8H6FN |
 |
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |